Cell Commun Signal 24 , 149 (2026)
Giles FJ, Miller CB, Hurd DD, Wingard JR, Fleming TR, Sonis ST, Bradford WZ, Pulliam JG, Anaissie EJ, Beveridge RA, Brunvand MM, Martin PJ, PROMPT-CT Trial Investigators: A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial)
The Role of Glutamine in the Complex Interaction between Gut Microbiota and Health: A Narrative Review
Treatment duration should always be individualized under medical supervision rather than following arbitrary timelines
Weight loss results: head-to-head data comparison No direct head-to-head trial between survodutide and tirzepatide has been conducted